Zhongchao Inc. Reports Decline in H1 2025 Financial Performance
Zhongchao Inc. (ZCMD) reported a decline in H1 2025 financial performance, with total revenues falling to $5.6 million from $8.3 million in H1 2024. The company experienced a net loss of $862,319, compared to a net income of $182,933 the previous year. Spark's AI Analyst rates ZCMD as Neutral, citing significant financial struggles, negative cash flows, and a bearish technical trend. Valuation metrics are unfavorable, indicating limited investor appeal. Zhongchao operates in the healthcare sector, focusing on medical services and training.
The latest update is out from Zhongchao ( (ZCMD) ).
Zhongchao Inc. released its unaudited interim financial statements for the six months ending June 30, 2025, showing a decline in total revenues to $5.6 million from $8.3 million in the same period of 2024. The company reported a net loss of $862,319 for the first half of 2025, compared to a net income of $182,933 in the previous year, reflecting challenges in both service and product revenue streams.
Spark’s Take on ZCMD Stock
According to Spark, TipRanks’ AI Analyst, ZCMD is a Neutral.
Zhongchao’s overall stock score is low primarily due to significant financial struggles, including negative cash flows and net losses. Technical analysis indicates a bearish trend, further weighing on the stock. Valuation metrics are also unfavorable, with a negative P/E ratio and no dividend yield, suggesting limited investor appeal at present.
To see Spark’s full report on ZCMD stock, click here.
More about Zhongchao
Zhongchao Inc. is a Cayman Islands exempted company operating in the healthcare industry, primarily focusing on providing medical-related services and products. The company is headquartered in Shanghai, China, and is involved in offering educational and training services to healthcare professionals.
Average Trading Volume: 23,080
Technical Sentiment Signal: Sell
Current Market Cap: $27.78M
